Evexia Lifecar Intrinsic Value
Evexia Lifecar intrinsic value. Evexia Lifecar (EVEXIA) median intrinsic value is ₹4.97 from 4 valuation models (range ₹3–₹5), vs current price ₹1.99 — +149.7% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit Evexia Lifecar screener.
EVEXIA Valuation Methods Summary — DCF, Graham Number & P/E
Evexia Lifecar intrinsic value across 4 models vs current price ₹1.99 — upside/downside and value range per method. Compare with EVEXIA fair price to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹4.97 | ₹4.47 - ₹5.47 | +149.7% | Book Value/Share: ₹18.17, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹3.98 | ₹3.58 - ₹4.38 | +100.0% | Revenue/Share: ₹20.85, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹3.38 | ₹3.04 - ₹3.72 | +69.8% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹4.97 | ₹3.98 - ₹5.96 | +149.7% | CF Growth: 15.0%, Discount: 15% |
EVEXIA Intrinsic Value vs Market Price — All Valuation Models
Evexia Lifecar fair value range ₹3–₹5 vs current market price ₹1.99 across 4 valuation models. Read EVEXIA ex-dividend dates for the complete payout history and dividend yield track record.
EVEXIA Intrinsic Value Analysis — Undervalued or Overvalued?
Evexia Lifecar median intrinsic value ₹4.97, current price ₹1.99 — Trading Below Calculated Value by 149.7%, margin of safety 60.0%.
What is the intrinsic value of EVEXIA?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Evexia Lifecar (EVEXIA) is ₹4.97 (median value). With the current market price of ₹1.99, this represents a +149.7% variance from our estimated fair value.
The valuation range spans from ₹3.38 to ₹4.97, indicating ₹3.38 - ₹4.97.
Is EVEXIA undervalued or overvalued?
Based on our multi-method analysis, Evexia Lifecar (EVEXIA) appears to be trading below calculated value by approximately 149.7%.
EVEXIA Financial Health — Key Ratios vs Industry Benchmarks
Evexia Lifecar financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.14 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 3.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.17x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
EVEXIA Cash Flow Quality — Operating & Free Cash Flow
Evexia Lifecar operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹17 Cr | ₹9 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-3 Cr | ₹-352 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2020 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |